Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1981 February; 74(2): 132–139.
PMCID: PMC1438626

Nutritional status and general immune competence in patients with head and neck cancer1


Anergy to 2,4-dinitrochlorobenzene (DNCB) has been reported as a highly significant adverse prognostic immunological factor in several studies of patients with squamous cell carcinomas involving the head and neck. Patients with these tumours often present with concurrent nutritional deficiencies. This paper reports the findings of a prospective study into both the nutritional status and general immune competence of 53 such patients.

Analysis of the results has demonstrated a statistically highly significant positive correlation between nutritional status and both the delayed hypersensitivity response to DNCB, and the pretreatment total lymphocyte count levels. It is suggested that nutritional deficit may be a primary adverse prognostic factor in this disease group, with immunoincompetence a secondary phenomenon, and supporting evidence is presented. The consequent probable importance of nutritional status with regard to clinical trials, and the necessity for controlled studies to determine the possible beneficial effect of nutritional support on `cure' rates, are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (992K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bates SE, Suen JY, Tranum BL. Immunological skin testing and interpretation: a plea for uniformity. Cancer. 1979 Jun;43(6):2306–2314. [PubMed]
  • Bistrian BR, Blackburn GL, Hallowell E, Heddle R. Protein status of general surgical patients. JAMA. 1974 Nov 11;230(6):858–860. [PubMed]
  • Bistrian BR, Blackburn GL, Sherman M, Scrimshaw NS. Therapeutic index of nutritional depletion in hospitalized patients. Surg Gynecol Obstet. 1975 Oct;141(4):512–516. [PubMed]
  • Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977;1(1):11–22. [PubMed]
  • Bolton PM. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients. Clin Oncol. 1975 Mar;1(1):59–69. [PubMed]
  • Catalona WJ, Sample WF, Chretien PB. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer. 1973 Jan;31(1):65–71. [PubMed]
  • Catalona WJ, Taylor PT, Rabson AS, Chretien PB. A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med. 1972 Feb 24;286(8):399–402. [PubMed]
  • Catalona WJ, Taylor PT, Chretien PB. Quantitative dinitrochlorobenzene contact sensitization in a normal population. Clin Exp Immunol. 1972 Nov;12(3):325–333. [PubMed]
  • Chandra RK. Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition. Br Med J. 1974 Sep 7;3(5931):608–609. [PMC free article] [PubMed]
  • Chernow B, Castell DO. Nutritional balance in patients with malignant disease of the oral cavity. Otolaryngol Clin North Am. 1979 Feb;12(1):161–166. [PubMed]
  • Clifford P, O'Connor AD, Durden-Smith J, Hollis BA, Edwards WG, Dalley VM. Synchronous multiple drug chemotherapy and radiotherapy for advanced (stage III and IV) squamous carcinoma of the head and neck. Antibiot Chemother (1971) 1978;24:60–72. [PubMed]
  • Copeland EM, Fadyen BV, Jr, Dudrick SJ. Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient. Ann Surg. 1976 Jul;184(1):60–64. [PubMed]
  • Edelman R, Suskind R, Olson RE, Sirisinha S. Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet. 1973 Mar 10;1(7802):506–508. [PubMed]
  • Eilber FR, Morton DL. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. [PubMed]
  • Eilber FR, Morton DL, Ketcham AS. Immunologic abnormalities in head and neck cancer. Am J Surg. 1974 Oct;128(4):534–538. [PubMed]
  • Geefhuysen J, Rosen EU, Katz J, Ipp T, Metz J. Impaired cellular immunity in kwashiorkor with improvement after therapy. Br Med J. 1971 Nov 27;4(5786):527–529. [PMC free article] [PubMed]
  • Jenkins VK, Ray P, Ellis HN, Griffiths CM, Perry RR, Olson MH. Lymphocyte response in patients with head and neck cancer: effect of clinical stage and radiotherapy. Arch Otolaryngol. 1976 Oct;102(10):596–600. [PubMed]
  • Krant MJ, Manskopf G, Brandrup CS, Madoff MA. Immunologic alterations in bronchogenic cancer. Sequential study. Cancer. 1968 Apr;21(4):623–631. [PubMed]
  • Law DK, Dudrick SJ, Abdou NI. Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion. Ann Intern Med. 1973 Oct;79(4):545–550. [PubMed]
  • Law DK, Dudrick SJ, Abdou NI. The effects of protein calorie malnutrition on immune competence of the surgical patient. Surg Gynecol Obstet. 1974 Aug;139(2):257–266. [PubMed]
  • Lederman M. Cancer of the upper jaw and nasal chambers. Proc R Soc Med. 1969 Jan;62(1):65–72. [PMC free article] [PubMed]
  • Lee YT, Sparks FC, Eilber FR, Morton DL. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer. Cancer. 1975 Mar;35(3):748–755. [PubMed]
  • Lundy J, Wanebo H, Pinsky C, Strong E, Oettgen H. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck. Am J Surg. 1974 Oct;128(4):530–533. [PubMed]
  • Maisel RH, Ogura JH. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma. Laryngoscope. 1973 Dec;83(12):2012–2019. [PubMed]
  • Mandel MA, Kiehn CL. The prognostic significance of delayed cutaneous reactivity in head and neck cancer patients. Plast Reconstr Surg. 1974 Jan;53(1):72–76. [PubMed]
  • Parker R, Alexander S, Shaheen OH, Parkes P. On the immunology of head and neck cancer--a prognostic index. Preliminary communication. J Laryngol Otol. 1975 Jul;89(7):687–695. [PubMed]
  • Smythe PM, Brereton-Stiles GG, Grace HJ, Mafoyane A, Schonland M, Coovadia HM, Loening WE, Parent MA, Vos GH. Thymolymphatic deficiency and depression of cell-mediated immunity in protein-calorie malnutrition. Lancet. 1971 Oct 30;2(7731):939–943. [PubMed]
  • Stefano S, Kerman R, Abbate J. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy. AJR Am J Roentgenol. 1976 Apr;126(4):880–886. [PubMed]
  • Theologides A. Pathogenesis of cachexia in cancer. A review and a hypothesis. Cancer. 1972 Feb;29(2):484–488. [PubMed]
  • Theologides A. Cancer cachexia. Cancer. 1979 May;43(5 Suppl):2004–2012. [PubMed]
  • Twomey PL, Catalona WJ, Chretien PB. Proceedings: Cellular immunity in cured cancer patients. Cancer. 1974 Feb;33(2):435–440. [PubMed]
  • Wanebo HJ, Jun MY, Strong EW, Oettgen H. T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg. 1975 Oct;130(4):445–451. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press